| Patents for C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings (20,978) |
|---|
| 05/06/2004 | WO2004037773A1 Phenethanolamine derivative for the treatment of respiratory diseases |
| 05/06/2004 | WO2004037251A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 and type 2 |
| 05/06/2004 | WO2003040096A3 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 05/06/2004 | US20040087798 Novel amide compounds |
| 05/06/2004 | US20040087650 Inhibitors of IMPDH enzyme |
| 05/06/2004 | US20040087636 Carboxylic acid derivative and a pharmaceutical composition containing the derivative as active ingredient |
| 05/06/2004 | US20040087635 Administering insulin sensitizer; benign prostatic hyperplasia |
| 05/06/2004 | US20040087627 Decarboxylase inhibitors; cardiovascular diosrders; antidiabetic agents; anticancer agents; dietetics |
| 05/06/2004 | US20040087585 Peptide deformylase inhibitors |
| 05/06/2004 | US20040087582 Anticaogulants; cardiovascular disorders; Factor x inhibitors; antiinflammatory agents |
| 05/06/2004 | US20040087453 Photo-labile pro-fragrance conjugates |
| 05/06/2004 | EP1415991A1 Process for the purification of N-carboxyanhydrides |
| 05/06/2004 | EP1414809A1 Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation |
| 05/06/2004 | EP1414788A1 Naphthylurea and naphthylacetamide derivatives as vanilloid receptor 1 (vr1) antagonists |
| 05/06/2004 | EP1261600B1 Heteroaromatic carboxamide derivatives and their use as inhibitors of the enzyme ikk-2 |
| 05/06/2004 | EP0915825B1 Substituted tetrahydronaphthalene and dihydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity |
| 05/06/2004 | CA2503588A1 Phenethanolamine derivative for the treatment of respiratory diseases |
| 05/06/2004 | CA2501228A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 and type 2 |
| 05/05/2004 | CN1148361C Oxyiminoalkanoic acid derivatives |
| 05/04/2004 | US6730792 β3 adrenergic agonists |
| 05/04/2004 | US6730783 Reacting aminoguanidine with carbonyl compound to form amidinohydrazone; reduction; reacting with alkoxyamine; guanidinylation; anticoagulants |
| 05/04/2004 | US6730671 Compounds useful as reversible inhibitors of cathespin S |
| 05/04/2004 | US6730669 Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors |
| 04/29/2004 | WO2004035589A1 Heterocyclocarboxamide derivatives |
| 04/29/2004 | WO2004035526A1 Process for producing aromatic nitrile compound |
| 04/29/2004 | WO2004035522A1 Diagnostic probes and remedies for diseases with accumulation of prion protein, and stains for prion protein |
| 04/29/2004 | WO2004016221A3 Sulfonamides as potassium channel blockers |
| 04/29/2004 | WO2004012732A3 Use of a proteasome inhibitor in the treatment of endothelial dysfunction and/or in a low-dose proteasome inhibitor therapy |
| 04/29/2004 | WO2003093242A3 Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade |
| 04/29/2004 | WO2002078626A3 Therapeutic combinations for cardiovascular and inflammatory indications |
| 04/29/2004 | US20040082780 Vanilloid receptor ligands and their use in treatments |
| 04/29/2004 | US20040082651 Epothilone synthesis building blocks III and IV: asymmetrically substituted acyloins and acyloin derivatives, methods for their production and methods for the production of epothilones B, D and epothilone derivatives |
| 04/29/2004 | US20040082628 Acylated arylcycloalkylamines and their use as pharmaceuticals |
| 04/29/2004 | US20040082625 Osteoporosis, bone disorders |
| 04/29/2004 | US20040082585 Anticoagulants; controlling thrombosis; cardiovascular disorders |
| 04/29/2004 | US20040082583 Chemical compounds |
| 04/29/2004 | US20040082562 Novel inhibitors of IMPDH enzyme |
| 04/29/2004 | US20040082553 Novel florfenicol-type antibiotics |
| 04/29/2004 | CA2496633A1 Diagnostic probes and remedies for diseases with accumulation of prion protein, and stains for prion protein |
| 04/28/2004 | EP1413576A2 Substituted imidazole derivatives having agonist-like activity at alpha 2B or 2B/2C adrenergic receptors |
| 04/28/2004 | EP1412326A1 Butyric acid derivatives |
| 04/28/2004 | EP1263718B1 Novel use of phenylheteroalkylamine derivatives |
| 04/28/2004 | EP1244642B1 Substituted oxazoles and thiazoles derivatives as hppar alpha activators |
| 04/28/2004 | EP1200384B1 2-alkyl-5-halogen-pent-4-ene carboxylic acids and their production |
| 04/28/2004 | CN1491937A 农药 Pesticide |
| 04/28/2004 | CN1147493C Oxazolo, thiazole and selenazolo [4,5-C]-quinolin-4-amines and analoges thereof and pharmaceutical composition containing them |
| 04/27/2004 | US6727271 Oxazole or thiazole derivatives; antilipemic agents, hypotensives, antineoplastic agents |
| 04/22/2004 | WO2004033652A2 Inhibitors of fatty acid amide hydrolase |
| 04/22/2004 | WO2004033415A1 Nitroaniline-based alkylating agents and their use as prodrugs |
| 04/22/2004 | WO2004032882A2 Chemical compounds |
| 04/22/2004 | WO2003082263A8 Sulfamic acids as inhibitors of human cytoplasmic protein tyrosine phosphatases |
| 04/22/2004 | US20040077876 Processes for the preparation of oxo-oxazoline or alloamino acid derivatives |
| 04/22/2004 | US20040077875 (5-(((2,4,6-Trimethylphenyl)amino)carbonyl)-4-methyl-2 -thiazolyl)carbamic Acid, 1,1-dimethylethyl ester for example; treating immunological and oncological disorders such as inflammatory bowel disease or cancer |
| 04/22/2004 | US20040077696 Heterocyclic inhibitors of kinases |
| 04/22/2004 | US20040077689 Abc expression promoters |
| 04/22/2004 | US20040077633 N-Heterocyclic derivatives; picornavirus infections in mammals; human rhinovirus |
| 04/22/2004 | US20040077631 Cyclization of amine with N-substituted diethanolamine; salt formation |
| 04/22/2004 | US20040077626 In vivo stability; very low metabolism rate |
| 04/22/2004 | CA2501575A1 Inhibitors of fatty acid amide hydrolase |
| 04/21/2004 | EP1410822A1 Oxa(thia)zolidine compounds, process for preparation thereof and anti-inflammatory agents |
| 04/21/2004 | EP1410799A1 Methods and pharmaceutical compositions for inhibiting tumour cell growth |
| 04/21/2004 | EP1409466A2 Hiv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis |
| 04/21/2004 | EP1409465A2 Oxazolidinone derivatives as antimicrobials |
| 04/21/2004 | EP1409464A1 Oxazolidinone derivatives as potential antimicrobials |
| 04/21/2004 | EP1409450A1 N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds |
| 04/21/2004 | EP0904262B1 Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and method |
| 04/21/2004 | CN1491218A Method for preparing compounds derived from thiazolidinedione, oxazolidinedione |
| 04/21/2004 | CN1491208A Acylated 6,7,8,9-tetrahydro-5H-benzocycloheptenyl amines and their use as pharmaceutical |
| 04/21/2004 | CN1146683C Optical brightening agent |
| 04/21/2004 | CN1146563C Piperidinylmethyloxazolidinone derivative |
| 04/21/2004 | CN1146560C Substituted benzoylpyrazoles as herbicides |
| 04/21/2004 | CN1146549C Sulphenylxazolamines as therapeutic active ingredients |
| 04/21/2004 | CN1146536C Cycloethylene derivatives |
| 04/20/2004 | US6723854 Preparing intermediates for epithilone a and b, desoxyepothilone a and b, and analogues thereof; haloalkadienyl thiazoles, the aldehyde intermediates; phosphorus halomethylene transfer agent |
| 04/20/2004 | US6723753 Substituted n-benzyl-n-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |
| 04/20/2004 | US6723740 Administering therapeutic amount of human peroxisome proliferator activated receptor delta agonist to lower triglycerides |
| 04/20/2004 | US6723731 3-(4-(2-(5h-dibenzo(a,d)cyclohepten-5-yloxy)-ethoxyl-phenyl)-2 -ethoxy-propionic acid ethyl ester as antidiabetic agents and to treat obesity |
| 04/15/2004 | WO2004031294A1 Synergistic uv absorber combination |
| 04/15/2004 | WO2004031162A1 Chirale oxazole-arylpropionic acid derivatives and their use as ppar agonists |
| 04/15/2004 | WO2004020445A3 4-(3,3-dihalo-allyloxy) phenol derivatives having pesticidal properties |
| 04/15/2004 | WO2003061552A3 Novel process for the preparation of substantially pure 5-(3,5-dimethylphenoxy)methyl-2-oxazolidinone |
| 04/15/2004 | WO2002083111A3 Imidazole, thiazole and oxazole derivatives and their use for the manufacture of a medicament for the treatment and/or prevention of pollakiuria or urinary incontinence |
| 04/15/2004 | US20040073049 Process for preparing intermediates for the manufacture of discodermolide and discodermolide analogues |
| 04/15/2004 | US20040073026 Cyclic protein tyrosine kinase inhibitors |
| 04/15/2004 | US20040072881 Dietetics; osteoporosis; muscular disorders |
| 04/15/2004 | US20040072854 Antiemetics; psychlogical disorders; antidepressants; anxiolytic agents; antitussive agents |
| 04/15/2004 | US20040072842 Difluorothioacetamides of oxazolidinones with a glycoloylpiperazine substituent |
| 04/15/2004 | US20040072841 Topical administration of oxazolidinones for transdermal delivery |
| 04/15/2004 | US20040072838 Thiazole and oxazole derivatives as activators of human peroxisome proliferator activated receptors |
| 04/15/2004 | US20040071640 Photostability; skin and hair protecting agents |
| 04/14/2004 | EP1406898A1 Substituted piperazine compounds and their use as fatty acid oxidation inhibitors |
| 04/14/2004 | EP1406880A1 Crystalline thiazine oxazolidinones |
| 04/14/2004 | EP1406696A1 Use of compositions comprising cyclooxygenase-2 selective inhibitors in combination with radiation for inhibition or prevention of cardiovascular disease |
| 04/14/2004 | EP1406617A1 Diaminediols for the treatment of alzheimer's disease |
| 04/14/2004 | EP1305270B1 Kinetic resolutions of chiral 2- and 3-substituted carboxylic acids |
| 04/14/2004 | EP1274426B1 Use of thioamide oxazolidinones for the treatment of bone resorption and osteoporosis |
| 04/14/2004 | EP1180515B1 Benzoxazole compounds, process for the preparation thereof and herbicides |
| 04/14/2004 | EP1161416B1 Alpha-aminoacetic acid derivatives useful as alpha 4 beta 7 - receptor antagonists |
| 04/14/2004 | EP1102757B1 Substituted oxazole and thiazole derivatives as hppar gamma and hppar alpha activators |
| 04/14/2004 | CN1489582A Dihydronaphthalene devivatives and drugs contanining these compounds as active ingrdeient |